vs

Side-by-side financial comparison of Alignment Healthcare, Inc. (ALHC) and ITRON, INC. (ITRI). Click either name above to swap in a different company.

Alignment Healthcare, Inc. is the larger business by last-quarter revenue ($1.0B vs $587.0M, roughly 1.7× ITRON, INC.). ITRON, INC. runs the higher net margin — 9.1% vs -1.1%, a 10.2% gap on every dollar of revenue. On growth, Alignment Healthcare, Inc. posted the faster year-over-year revenue change (44.4% vs -3.3%). ITRON, INC. produced more free cash flow last quarter ($79.0M vs $-55.4M). Over the past eight quarters, Alignment Healthcare, Inc.'s revenue compounded faster (26.9% CAGR vs -1.8%).

Alignment Healthcare, Inc. is a U.S.-based healthcare provider offering Medicare Advantage plans for seniors. It adopts a value-based care model, partnering with local providers to deliver personalized coordinated medical services, prescription drug coverage and supplemental benefits to members across multiple U.S. states.

Itron, Inc. is an American technology company that offers products and services for energy and water resource management. It is headquartered in Liberty Lake, Washington, United States. The company's products measure and analyze electricity, gas and water consumption. Its products include electricity, gas, water and thermal energy measurement devices and control technology, communications systems, software, as well as managed and consulting services.

ALHC vs ITRI — Head-to-Head

Bigger by revenue
ALHC
ALHC
1.7× larger
ALHC
$1.0B
$587.0M
ITRI
Growing faster (revenue YoY)
ALHC
ALHC
+47.8% gap
ALHC
44.4%
-3.3%
ITRI
Higher net margin
ITRI
ITRI
10.2% more per $
ITRI
9.1%
-1.1%
ALHC
More free cash flow
ITRI
ITRI
$134.4M more FCF
ITRI
$79.0M
$-55.4M
ALHC
Faster 2-yr revenue CAGR
ALHC
ALHC
Annualised
ALHC
26.9%
-1.8%
ITRI

Income Statement — Q4 FY2025 vs Q1 FY2026

Metric
ALHC
ALHC
ITRI
ITRI
Revenue
$1.0B
$587.0M
Net Profit
$-11.0M
$53.6M
Gross Margin
40.3%
Operating Margin
-1.0%
11.5%
Net Margin
-1.1%
9.1%
Revenue YoY
44.4%
-3.3%
Net Profit YoY
64.6%
-18.0%
EPS (diluted)
$-0.04
$1.18

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
ALHC
ALHC
ITRI
ITRI
Q1 26
$587.0M
Q4 25
$1.0B
$571.7M
Q3 25
$993.7M
$581.6M
Q2 25
$1.0B
$606.8M
Q1 25
$926.9M
$607.2M
Q4 24
$701.2M
$612.9M
Q3 24
$692.4M
$615.5M
Q2 24
$681.3M
$609.1M
Net Profit
ALHC
ALHC
ITRI
ITRI
Q1 26
$53.6M
Q4 25
$-11.0M
$101.6M
Q3 25
$3.7M
$65.6M
Q2 25
$15.7M
$68.3M
Q1 25
$-9.1M
$65.5M
Q4 24
$-31.1M
$58.1M
Q3 24
$-26.4M
$78.0M
Q2 24
$-24.0M
$51.3M
Gross Margin
ALHC
ALHC
ITRI
ITRI
Q1 26
40.3%
Q4 25
40.5%
Q3 25
37.7%
Q2 25
36.9%
Q1 25
35.8%
Q4 24
34.9%
Q3 24
34.1%
Q2 24
34.6%
Operating Margin
ALHC
ALHC
ITRI
ITRI
Q1 26
11.5%
Q4 25
-1.0%
13.8%
Q3 25
0.8%
14.1%
Q2 25
2.2%
12.6%
Q1 25
-0.6%
12.6%
Q4 24
-3.2%
10.2%
Q3 24
-2.8%
12.0%
Q2 24
-2.7%
10.6%
Net Margin
ALHC
ALHC
ITRI
ITRI
Q1 26
9.1%
Q4 25
-1.1%
17.8%
Q3 25
0.4%
11.3%
Q2 25
1.5%
11.3%
Q1 25
-1.0%
10.8%
Q4 24
-4.4%
9.5%
Q3 24
-3.8%
12.7%
Q2 24
-3.5%
8.4%
EPS (diluted)
ALHC
ALHC
ITRI
ITRI
Q1 26
$1.18
Q4 25
$-0.04
$2.20
Q3 25
$0.02
$1.41
Q2 25
$0.07
$1.47
Q1 25
$-0.05
$1.42
Q4 24
$-0.15
$1.26
Q3 24
$-0.14
$1.70
Q2 24
$-0.13
$1.10

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
ALHC
ALHC
ITRI
ITRI
Cash + ST InvestmentsLiquidity on hand
$604.2M
$712.9M
Total DebtLower is stronger
$323.2M
Stockholders' EquityBook value
$179.3M
$1.6B
Total Assets
$1.1B
$4.0B
Debt / EquityLower = less leverage
1.80×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
ALHC
ALHC
ITRI
ITRI
Q1 26
$712.9M
Q4 25
$604.2M
$1.0B
Q3 25
$644.1M
$1.3B
Q2 25
$503.8M
$1.2B
Q1 25
$479.5M
$1.1B
Q4 24
$470.6M
$1.1B
Q3 24
$381.0M
$982.5M
Q2 24
$363.7M
$920.6M
Total Debt
ALHC
ALHC
ITRI
ITRI
Q1 26
Q4 25
$323.2M
$1.3B
Q3 25
$322.7M
Q2 25
$322.3M
Q1 25
$321.9M
Q4 24
$321.4M
$1.3B
Q3 24
$212.0M
$1.3B
Q2 24
$211.7M
$1.3B
Stockholders' Equity
ALHC
ALHC
ITRI
ITRI
Q1 26
$1.6B
Q4 25
$179.3M
$1.7B
Q3 25
$161.9M
$1.7B
Q2 25
$141.0M
$1.6B
Q1 25
$108.1M
$1.5B
Q4 24
$99.9M
$1.4B
Q3 24
$114.5M
$1.3B
Q2 24
$123.7M
$1.2B
Total Assets
ALHC
ALHC
ITRI
ITRI
Q1 26
$4.0B
Q4 25
$1.1B
$3.7B
Q3 25
$1.1B
$3.7B
Q2 25
$1.0B
$3.6B
Q1 25
$895.6M
$3.5B
Q4 24
$782.1M
$3.4B
Q3 24
$692.3M
$3.4B
Q2 24
$716.3M
$3.3B
Debt / Equity
ALHC
ALHC
ITRI
ITRI
Q1 26
Q4 25
1.80×
0.74×
Q3 25
1.99×
Q2 25
2.29×
Q1 25
2.98×
Q4 24
3.22×
0.91×
Q3 24
1.85×
0.94×
Q2 24
1.71×
1.02×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
ALHC
ALHC
ITRI
ITRI
Operating Cash FlowLast quarter
$-50.4M
$85.5M
Free Cash FlowOCF − Capex
$-55.4M
$79.0M
FCF MarginFCF / Revenue
-5.5%
13.5%
Capex IntensityCapex / Revenue
0.5%
Cash ConversionOCF / Net Profit
1.60×
TTM Free Cash FlowTrailing 4 quarters
$113.1M
$394.6M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
ALHC
ALHC
ITRI
ITRI
Q1 26
$85.5M
Q4 25
$-50.4M
$119.3M
Q3 25
$144.6M
$117.8M
Q2 25
$29.1M
$96.7M
Q1 25
$16.6M
$72.1M
Q4 24
$-8.7M
$79.8M
Q3 24
$26.2M
$65.3M
Q2 24
$23.5M
$51.7M
Free Cash Flow
ALHC
ALHC
ITRI
ITRI
Q1 26
$79.0M
Q4 25
$-55.4M
$111.5M
Q3 25
$139.1M
$113.4M
Q2 25
$21.1M
$90.7M
Q1 25
$8.4M
$67.5M
Q4 24
$-18.0M
$70.2M
Q3 24
$16.9M
$58.7M
Q2 24
$11.8M
$44.6M
FCF Margin
ALHC
ALHC
ITRI
ITRI
Q1 26
13.5%
Q4 25
-5.5%
19.5%
Q3 25
14.0%
19.5%
Q2 25
2.1%
14.9%
Q1 25
0.9%
11.1%
Q4 24
-2.6%
11.4%
Q3 24
2.4%
9.5%
Q2 24
1.7%
7.3%
Capex Intensity
ALHC
ALHC
ITRI
ITRI
Q1 26
Q4 25
0.5%
1.4%
Q3 25
0.6%
0.8%
Q2 25
0.8%
1.0%
Q1 25
0.9%
0.8%
Q4 24
1.3%
1.6%
Q3 24
1.3%
1.1%
Q2 24
1.7%
1.2%
Cash Conversion
ALHC
ALHC
ITRI
ITRI
Q1 26
1.60×
Q4 25
1.17×
Q3 25
38.77×
1.80×
Q2 25
1.86×
1.41×
Q1 25
1.10×
Q4 24
1.37×
Q3 24
0.84×
Q2 24
1.01×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

ALHC
ALHC

Segment breakdown not available.

ITRI
ITRI

Product revenues$477.8M81%
Service revenues$109.2M19%

Related Comparisons